01:50 , Feb 10, 2015 |  BC Extra  |  Financial News

Vaxxas raises $20M in B round

Vaxxas Pty. Ltd. (Sydney, Australia) raised $20 million (A$25.7 million) toward a planned $23.3 million (A$30 million) series B round led by existing investor OneVentures. Undisclosed new investors also participated. CEO David Hoey said the...
07:00 , Aug 15, 2011 |  BioCentury  |  Finance

Validating Vaxxas

HealthCare Ventures, an early stage investor with a penchant for academic spinouts, recently made its first Australian investment in new vaccine company Vaxxas Pty Ltd. The Cambridge, Mass., firm participated in Vaxxas' first venture round,...
07:00 , Aug 8, 2011 |  BC Week In Review  |  Financial News

Vaxxas completes venture financing

Vaxxas Pty. Ltd. , Brisbane, Australia   Business: Drug delivery, Infectious   Date completed: 8/1/11   Type: Venture financing   Raised: A$15 million (US$16.6 million)   Investors: OneVentures; Brandon Capital Partners; Medical Research Commercialization Fund;...
00:12 , Aug 3, 2011 |  BC Extra  |  Financial News

Australian newco Vaxxas raises $16.6 million

Newco Vaxxas Pty Ltd. raised A$15 million ($16.6 million) in the Australian company's first venture round, which was led by OneVentures. Brandon Capital; the Medical Research Commercialization Fund (MRCF); the Brisbane Angels; and HealthCare Ventures...